Bioburden testing is performed before sterilization to measure the number and types of viable microorganisms contaminating a product.
It serves as a vital preventive tool to validate the sterilization process, ensure patient safety, and maintain compliance with manufacturing regulations.
๐๐ก๐ฒ ๐๐ฌ ๐๐ข๐จ๐๐ฎ๐ซ๐๐๐ง ๐๐๐ฌ๐ญ๐ข๐ง๐ ๐๐ฆ๐ฉ๐จ๐ซ๐ญ๐๐ง๐ญ?
Bioburden testing provides a measure of the contaminants present on a medical device or piece of equipment, just prior to the final sterilization process before implantation or patient interaction.
An accurate bioburden measurement allows for proper selection of sterilization process, as well as calibration and measurement of the level of sterilization required.
Bioburden also acts as an indicator of the level of control over contaminants in the manufacturing process.
Without a bioburden analyser, it is possible that improper or incorrect sterilization methods may be used, or that sterilization may not be executed thoroughly enough which may result in the presence of unwanted microbes when the device is implanted or used.
The vital step in bioburden testing is the collection of samples or recovery methods of microorganisms from products and medical devices. Bioburden testing is highly used in pharmaceutical industries, manufacturers of medical devices, and cosmetics industries.
Procedure of Bioburden Testing
- ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐ซ๐๐ฉ๐๐ซ๐๐ญ๐ข๐จ๐ง & ๐๐ฑ๐ญ๐ซ๐๐๐ญ๐ข๐จ๐ง
Microorganisms are removed from the product using suitable techniques such as rinsing, swabbing, sonication, or direct immersion, depending on the product type. - ๐๐ข๐๐ซ๐จ๐จ๐ซ๐ ๐๐ง๐ข๐ฌ๐ฆ ๐๐ฌ๐จ๐ฅ๐๐ญ๐ข๐จ๐ง
The extracted sample is filtered, usually through a 0.45 ยตm membrane filter, to capture microorganisms and remove any interfering substances. - ๐๐ฎ๐ฅ๐ญ๐ฎ๐ซ๐ข๐ง๐ & ๐๐ง๐๐ฎ๐๐๐ญ๐ข๐จ๐ง
The membrane or sample is transferred to appropriate culture media and incubated under specified conditions to allow microorganisms to grow. - ๐๐ง๐ฎ๐ฆ๐๐ซ๐๐ญ๐ข๐จ๐ง
After incubation, the colonies are counted and reported as Colony Forming Units (CFU). The results are expressed as Total Aerobic Microbial Count (TAMC) and Total Yeast and Mold Count (TYMC). - ๐๐๐ฌ๐ฎ๐ฅ๐ญ ๐๐ฏ๐๐ฅ๐ฎ๐๐ญ๐ข๐จ๐ง & ๐๐๐ฉ๐จ๐ซ๐ญ๐ข๐ง๐
The microbial count is compared with predefined acceptance criteria. The final results help assess process hygiene and determine whether the product is suitable for sterilization.
- ย
๐๐ก๐ฒ ๐๐ฌ ๐๐ข๐จ๐๐ฎ๐ซ๐๐๐ง ๐๐ฌ๐ฌ๐๐ฌ๐ฌ๐ฆ๐๐ง๐ญ ๐๐ฆ๐ฉ๐จ๐ซ๐ญ๐๐ง๐ญ?
A well-designed bioburden assessment helps pharmaceutical manufacturers:
- Evaluate the effectiveness of cleaning and sanitation
- Monitor the microbiological quality of the manufacturing process
- Support sterilization validation
- Detect contamination trends early
- Ensure GMP compliance
- Protect product quality and patient safety
ย ย ย ย ย